286 related articles for article (PubMed ID: 12545622)
21. Long-term rates of undetectable PSA with initial observation and delayed salvage radiotherapy after radical prostatectomy.
Loeb S; Roehl KA; Viprakasit DP; Catalona WJ
Eur Urol; 2008 Jul; 54(1):88-94. PubMed ID: 18400368
[TBL] [Abstract][Full Text] [Related]
22. Expression of p21 cell cycle protein is an independent predictor of response to salvage radiotherapy after radical prostatectomy.
Rigaud J; Tiguert R; Decobert M; Hovington H; Latulippe E; Laverdiere J; Larue H; Lacombe L; Fradet Y
Prostate; 2004 Feb; 58(3):269-76. PubMed ID: 14743466
[TBL] [Abstract][Full Text] [Related]
23. Successful salvage robotic-assisted radical prostatectomy after external beam radiotherapy failure.
Jamal K; Challacombe B; Elhage O; Popert R; Kirby R; Dasgupta P
Urology; 2008 Dec; 72(6):1356-8. PubMed ID: 18533232
[TBL] [Abstract][Full Text] [Related]
24. Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy: evaluation of prognostic factors and creation of a prognostic scoring system.
Buskirk SJ; Pisansky TM; Schild SE; Macdonald OK; Wehle MJ; Kozelsky TF; Collie AC; Ferrigni RG; Myers RP; Prussak KA; Heckman MG; Crook JE; Parker AS; Igel TC
J Urol; 2006 Sep; 176(3):985-90. PubMed ID: 16890677
[TBL] [Abstract][Full Text] [Related]
25. Sequential treatment for recurrent localized prostate cancer.
Van Der Poel HG; Moonen L; Horenblas S
J Surg Oncol; 2008 Apr; 97(5):377-82. PubMed ID: 18360820
[TBL] [Abstract][Full Text] [Related]
26. Postoperative prostate-specific antigen velocity independently predicts for failure of salvage radiotherapy after prostatectomy.
King CR; Presti JC; Brooks JD; Gill H; Spiotto MT
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1472-7. PubMed ID: 17935902
[TBL] [Abstract][Full Text] [Related]
27. Urinary continence after salvage radiation therapy following radical prostatectomy, assessed by a self-administered questionnaire: a prospective study.
Fontaine E; Ben Mouelli S; Thomas L; Otmezguine Y; Beurton D
BJU Int; 2004 Sep; 94(4):521-3. PubMed ID: 15329104
[TBL] [Abstract][Full Text] [Related]
28. Salvage radiotherapy for biochemical recurrence after radical prostatectomy.
Terai A; Matsui Y; Yoshimura K; Arai Y; Dodo Y
BJU Int; 2005 Nov; 96(7):1009-13. PubMed ID: 16225518
[TBL] [Abstract][Full Text] [Related]
29. Salvage robotic-assisted radical prostatectomy: initial results and early report of outcomes.
Boris RS; Bhandari A; Krane LS; Eun D; Kaul S; Peabody JO
BJU Int; 2009 Apr; 103(7):952-6. PubMed ID: 19076132
[TBL] [Abstract][Full Text] [Related]
30. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.
Ward JF; Slezak JM; Blute ML; Bergstralh EJ; Zincke H
BJU Int; 2005 Apr; 95(6):751-6. PubMed ID: 15794776
[TBL] [Abstract][Full Text] [Related]
31. Evaluation and management of prostate-specific antigen recurrence after radical prostatectomy for localized prostate cancer.
Naito S
Jpn J Clin Oncol; 2005 Jul; 35(7):365-74. PubMed ID: 15976063
[TBL] [Abstract][Full Text] [Related]
32. Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database.
Freedland SJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Dorey F; Presti JC;
J Urol; 2003 Jun; 169(6):2136-41. PubMed ID: 12771735
[TBL] [Abstract][Full Text] [Related]
33. [Pathological stage T3 prostate cancer after radical prostatectomy: a retrospective study of 246 cases].
Roche JB; Malavaud B; Soulié M; Cournot M; Gamé X; Mazerolles C; Bachaud JM; Plante P; Rischmann P
Prog Urol; 2008 Oct; 18(9):586-94. PubMed ID: 18986631
[TBL] [Abstract][Full Text] [Related]
34. [Salvage radiotherapy for patients with PSA relapse after radical prostatectomy: comparisons among ASTRO and Phoenix biochemical failure definitions].
Quero L; Mongiat-Artus P; Ravery V; Hennequin V; Maylin C; Desgrandchamps F; Hennequin C
Cancer Radiother; 2009 Jul; 13(4):267-75. PubMed ID: 19446487
[TBL] [Abstract][Full Text] [Related]
35. Outcome of salvage radiotherapy for biochemical failure after radical prostatectomy with or without hormonal therapy.
Cheung R; Kamat AM; de Crevoisier R; Allen PK; Lee AK; Tucker SL; Pisters L; Babaian RJ; Kuban D
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):134-40. PubMed ID: 16111581
[TBL] [Abstract][Full Text] [Related]
36. Management of biochemical failure following radical prostatectomy: salvage radiotherapy - a case series.
Stockdale AD; Vakkalanka BK; Fahmy A; Desai K; Blacklock AR
Prostate Cancer Prostatic Dis; 2007; 10(2):205-9. PubMed ID: 17310262
[TBL] [Abstract][Full Text] [Related]
37. [Salvage radiotherapy in rising PSA after radical prostatectomy].
Carrie C; Pommier P
Cancer Radiother; 2007 Nov; 11(6-7):370-2. PubMed ID: 17869564
[TBL] [Abstract][Full Text] [Related]
38. Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy.
Pisters LL; Leibovici D; Blute M; Zincke H; Sebo TJ; Slezak JM; Izawa J; Ward JF; Scott SM; Madsen L; Spiess PE; Leibovich BC
J Urol; 2009 Aug; 182(2):517-25; discussion 525-7. PubMed ID: 19524984
[TBL] [Abstract][Full Text] [Related]
39. Prostate-specific antigen velocity accurately predicts response to salvage radiotherapy in men with biochemical relapse after radical prostatectomy.
Patel R; Lepor H; Thiel RP; Taneja SS
Urology; 2005 May; 65(5):942-6. PubMed ID: 15882728
[TBL] [Abstract][Full Text] [Related]
40. Pre-operative percent free PSA predicts clinical outcomes in patients treated with radical prostatectomy with total PSA levels below 10 ng/ml.
Shariat SF; Abdel-Aziz KF; Roehrborn CG; Lotan Y
Eur Urol; 2006 Feb; 49(2):293-302. PubMed ID: 16387412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]